Prof. Dr. Ümit SARICI

Prof. Dr. Ümit SARICI

Çocuk Sağlığı ve Hastalıkları Anabilim Dalı

0850 308 8385

serdarumit.sarici@ufuk.edu.tr

RANDEVU ALIN

Özgeçmiş

 

PROF. DR. S.ÜMİT SARICI

EĞİTİM

Mezun Olduğu Tıp Fakültesi ve Yılı

GATA Askeri Tıp Fakültesi 1990

Uzmanlık Eğitimi Aldığı Yer ve Yılı

Çocuk Sağlığı ve Hastalıkları Uzmanlık: GATA Çocuk Sağlığı ve Hastalıkları Anabilim Dalı 1993-1997

Neonatoloji Uzmanlık: Hacettepe Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları Anabilim Dalı Neonatoloji Bilim Dalı: 2000-2002

 

MESLEKİ DENEYİM

 Çocuk Sağlığı ve Hastalıkları Uzmanı: GATA Çocuk Sağlığı ve Hastalıkları Anabilim Dalı 1997-2000

Çocuk Sağlığı ve Hastalıkları Yardımcı Doçenti: GATA Çocuk Sağlığı ve Hastalıkları Anabilim Dalı 2002-2004

Çocuk Sağlığı ve Hastalıkları Doçenti: GATA Çocuk Sağlığı ve Hastalıkları Anabilim Dalı 2004-2010

Çocuk Sağlığı ve Hastalıkları Profesörü: GATA Çocuk Sağlığı ve Hastalıkları Anabilim Dalı 2010-2012

Ufuk Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları Anabilim Dalı 2013-

ULUSLAR ARASI EĞİTİM VE GÖREVLER

3012.2008-22.03.2009

Michigan Wayne State University

Michigan State University

Oakland University

William Beaumont Children’s Hospital

Ulusal Saygın Ödüller

Bayındır Hastanesi 6. Tıp Ödülleri (2005) Teşvik Ödülü

TÜBİTAK Teşvik Ödülü (2006)

 

İDARİ GÖREVLER

GATA Çocuk Sağlığı ve Hastalıkları Anabilim Dalı Neonatoloji Bilim Dalı Başkanlığı: 2005-2012

 

Ufuk Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları Anabilim Dalı Neonatoloji Bilim Dalı Başkanlığı: 2013-

Ufuk Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları Anabilim Dalı Başkanlığı: 2014-

TIBBİ İLGİ ALANLARI

Genel Pediatri

Neonatoloji

Yenidoğan sarılıkları

 

ÜYELİKLER

Türk Neonatoloji Derneği Üyeliği

 

YAYINLAR

Prof.Dr. S.Ümit SARICI’nın Aralık 2023 itibariyle (Uluslararası) Science Citation Index’ce taranan hakemli dergilerde çıkmış 125 yayını vardır ve bu yayınlara 1800’ün üzerinde atıf yapılmıştır.

 

Uluslararası hakemli dergilerde yayınlanan makaleler (SCI, SSCI, Arts and Humanities)

 

  1. Sarıcı SÜ, Babacan A, Çandar I, Sarıcı D. How effective is massage in newborns with neonatal hyperbilirubinemia? Explore (NY) 2023 Apr 28:S1550-8307(23)00105-2.
  2. Şimşek F, Sarıcı SÜ, Soylu D, Serdar MA, Özcan M, Sarici D. Predicting urinary tract infection in jaundiced newborns by phototherapy response. Int J Med Res Health Sci 2022; 11: 87-99.
  3. Sarıcı SÜ, Özcan M, Akpınar M, Altun D, Yaşartekin Y, Koklu E E, Serdar MA, Sarici D. Transcutaneous bilirubin levels and risk of significant hyperbilirubinemia in early-term and term newborns. J Obstet Gynecol Neonatal Nurs 2021; 50: 307-315.
  4. Alptekin B, Sarıcı SÜ, Serdar MA, Altun D. Comparison of the correlation of various site transcutaneous bilirubin measurements with serum bilirubin levels at the end of phototherapy. Acta Paediatr 2021; 110: 2072-2073.
  5. Arslan K, Sarıcı SÜ, Kolukısa G, Altun D. Familial Mediterranean Fever with Neonatal Onset: Case Report. Case Rep Pediatr 2020 Dec 14; 2020: 6649525.
  6. Yaşartekin Y, Sarıcı SÜ, Özcan M, Akpınar M, Altun D, Akın A, Serdar MA, Sarıcı D. Investigation of the relationship between cord clamping time and risk of hyperbilirubinemia. Turk J Pediatr 2020; 62: 756-762.
  7. Akın A, Sarıcı SÜ, Özcan M, Akpınar M, Altun D, Yaşartekin Y, Serdar MA, Sarıcı D. Transcutaneous bilirubinometry should be carried out in newborn infants at least seven hours after phototherapy finishes. Acta Paediatr 2018; 107: 1100-1101.
  8. Sarıcı D, Kurtoğlu S, Sarıcı SÜ, Yıkılmaz A, Akın MA, Güneş T, Öztürk MA, Narin N, Dündar M, Serdar M. Evaluation of aortic intima-media thickness in newborns with Down syndrome. Adv Clin Exp Med 2017; 26: 1253-1256.
  9. Özcan M, Sevinç S, Erkan VB, Yurdugül Y, Sarıcı SÜ. Hyperbilirubinemia due to minor blood group (anti-E) incompatibility in a newborn: a case report. Turk Pediatri Ars 2017; 52: 162-164.
  10. Özcan M, Sarici SU, Yurdugül Y, Akpinar M, Altun D, Özcan B, Serdar MA, Sarici D. Association between early idiopathic neonatal jaundice and urinary tract İnfections. Clinical Medicine Insights: Pediatrics 2017 Mar 30; 11: 1179556517701118.
  11. Erkan Boz V, Altun D, Serdar MA, Sarıcı SÜ. Should the second dose of measles vaccine be performed at an earlier age? Mathews J Pediatr 2017; 1 (1): 008.
  12. Sarıcı SÜ, Özcan M, Altun D. Neonatal polycythemia: a review. Clin Med Rev Case Rep 2016; 3: 142.
  13. Sarıcı SÜ, Güneş Ö, Köklü E, Serdar MA. Transcutaneous bilirubin bevels during the first month of life in term and late-preterm newborns. J Trop Pediatr 2017; 63: 4-9.
  14. Küçükevcilioğlu M, Mutlu FM, Sarıcı SÜ. Ocular morbidities of premature children with mild or no retinopathy of prematurity. Turk J Pediatr 2015; 57: 129-135.
  15. Cetinkaya M, Cansev M, Cekmez F, Tayman C, Canpolat FE, Kafa IM, Yaylagul EO, Kramer BW, Sarıcı SU. Protective effects of Valproic acid, a histone deacetylase inhibitor, against hyperoxic lung injury in a neonatal rat model. PLoS One 2015;10 (5): e0126028.
  16. Sarıcı SÜ, Gursel O, Kurekci E, Kesik V, Atay A, Okutan V, Inal A, Pekel A, Ozguven MA, Ozcan O. Anticardiolipin antibodies in children with Helicobacter pylori infection. Helicobacter 2015; 20: 418-421.
  17. Sarıcı D, Akin MA, Kurtoglu S, Tubas F, Sarıcı SÜ. A neonate with CLOVES syndrome. Case Rep Pediatr 2014; 2014: 845074.
  18. Konukbay D, Sarıcı SÜ, Akbayrak N. Analysis of the relationship between serum bilirubin levels and frequency of urination and stooling in infants in the first week of life. International Journal of Caring Sciences 2014; 7: 3.
  19. Sarıcı D, Gunes T, Yazici C, Akin MA, Korkmaz L, Memur S, Kurtoglu S, Ozturk MA, Sarıcı SÜ. Investigation on malondialdehyde, S100B, and advanced oxidation protein product levels in significant hyperbilirubinemia and the effect of intensive phototherapy on these parameters. Pediatr Neonatol 2015; 56: 95-100.
  20. Suleymanoglu S, Cekmez F, Cetinkaya M, Tayman C, Canpolat FE, Kafa IM, Tanju A, Arzıman IK, Fidancı M, Tunc T, Sarıcı SÜ. Protective effects of melatonin therapy in model for neonatal hyperoxic lung injury. Altern Ther Health Med 2014; 20: 24-29.
  21. Aygen S, Dürr U, Hegele P, Kunig J, Spraul M, Schäfer H, Krings D, Cannet C, Fang F, Schütz B, Bülbül SF, Aydin HI, Sarıcı SÜ, Yalaz M, Ors R, Atalan R, Tuncer O. NMR-based screening for inborn errors of metabolism: initial results from a study on Turkish neonates. JIMD Rep 2014; 16: 101-111.
  22. Sarıcı SÜ. ABO Incompatibility: Which one matters? Turk J Pediatr 2014; 56: 216.
  23. Sarıcı SÜ, Köklü E, Babacan O. Comparison of two transcutaneous bilirubinometers in term and near-term neonates. Neonatal Netw 2014; 33: 138-142.
  24. Küçükevcilioğlu M, Mutlu FM, Sarıcı SÜ, Ceylan OM, Altınsoy Hİ, Kılıç K, Çekmez F. Frequency, risk factors and outcomes of retinopathy of prematurity in a tertiary care hospital in Turkey. Turk J Pediatr 2013; 55: 467-474.
  25. Erdinç K, Sarıcı SÜ, Dabak O, Gürsel O, Güler A, Kürekçi AE, Canpolat FE. A neonatal thrombosis patient treated successfully with recombinant tissue plasminogen activator. Turk J Hematol 2013; 30: 325-327.
  26. Sarıcı D, Akın MA, Kurtoğlu S, Yıkılmaz A, Muhtaroğlu S, Öztürk MA, Güneş T, Sarıcı SÜ. Investigation into the relationship between cord blood adiponectin levels and aortic intima media thickness in healthy, term neonates. Eur Cytokine Netw 2013; 24: 104-109.
  27. Erdinç K, Sarıcı SÜ, Akgül EO, Ağilli M, Ozcan O. Relationship between neonatal adrenomedullin and bilirubin levels. J Matern Fetal Neonatal Med 2014; 27: 30-35.
  28. Mutlu FM, Küçükevcilioğlu M, Ceylan OM, Altınsoy Hİ, Sarıcı SÜ. Risk factor analysis for long-term unfavorable ocular outcomes in children treated for retinopathy of prematurity. Turk J Pediatr 2013; 55: 35-41.
  29. Mutlu FM, Sarıcı SÜ. Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol 2013; 6: 228-236.
  30. Çetinkaya M, Cansev M, Kafa IM, Tayman C, Çekmez F, Canpolat FE, Tunc T, Sarıcı SÜ. Cytidine 5’-diphosphocholine (CDP-choline) ameliorates hyperoxic lung injury in a neonatal rat model. Pediatr Res 2013; 74: 26-33.
  31. Çekmez F, Çetinkaya M, Tayman C, Canpolat FE, Kafa IM, Uysal S, Tunc T, Sarıcı SÜ. Evaluation of melatonin and prostaglandin E1 combination on necrotizing enterocolitis model in neonatal rats. Regul Pept 2013; 184: 121-125.
  32. Çekmez F, Canpolat FE, Pirgon O, Aydemir G, Tanju IA, Genc FA, Tunc T, Aydınöz S, Yıldırım S, İpcioglu OM, Sarıcı SÜ. Adiponectin and visfatin levels in extremely low birth weight infants: they are also at risk for insulin resistance. Eur Rev Med Pharmacol Sci 2013; 17: 501-506.
  33. Çekmez F, Tanju IA, Canpolat FE, Aydınöz S, Aydemir G, Karademir F, Sarıcı SÜ. Mean platelet volume in very preterm infants: a pedictor of morbidities? Eur Rev Med Pharmacol Sci 2013; 17: 134-137.
  34. Tunç T, Aydemir G, Karaoglu A, Cekmez F, Kul M, Aydinoz S, Babacan O, Yaman H, Sarıcı SÜ. Toll-like receptor levels and caffeine responsiveness in rat pups during perinatal period. Regul Pept 2013; 182: 41-44.
  35. Karaoğlu A, Tunç T, Aydemir G, Onguru O, Uysal B, Kul M, Aydinoz S, Oztas E, Sarıcı Ü. Role of cyclooxygenase 2 and endothelial nitric oxide synthetase in preclinical atherosclerosis. Fetal Pediatr Pathol 2012; 31: 432-438.
  36. Tunç T, Sarıcı Ü, Aydinoz S, Onguru O, Karaoglu A, Uysal B, Kul M, Sirin YS, Oztas E, Yaman H. Passive smoke exposure of female rats caused aortic atherosclerotic precursor lesions in their offspring. Fetal Pediatr Pathol 2012; 31: 120-127.
  37. Karaoğlu A, Tunc T, Aydemir G, Ongoru O, Aydinoz S, Uysal B, Erdem G, Guven A, Oztas E, Sarıcı SÜ. Effects of maternal smoking on fetal organs. Adv Clin Exp Med 2012; 21: 441-446.
  38. Çetinkaya M, Cansev M, Çekmez F, Tayman C, Canpolat FE, Kafa IM, Uysal S, Tunc T, Sarıcı SÜ. CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis. J Surg Res 2013; 183: 119-128.
  39. Çekmez F, Tayman C, Sağlam C, Çetinkaya M, Bedir O, Günal A, Tunc T, Sarıcı SÜ. Well-known but rare pathogen in neonates: Listeria monocytogenes. Eur Rev Med Pharmacol Sci 2012; 16 (4 Suppl): 58-61.
  40. Aydemir G, Çekmez F, Tanju IA, Canpolat FE, Genç FA, Yıldırım Ş, Tunc T, Sarıcı SÜ. Increased fecal calprotectin in preterm infants with necrotizing enterocolitis. Clin Lab 2012; 58: 841-844.
  41. Tayman C, Cekmez F, Kafa IM, Canpolat FE, Cetinkaya M, Tonbul A, Uysal S, Tunc T, Sarıcı SÜ. Protective effects of nigella sativa oil in hyperoxia-induced lung injury. Arch Bronconeumol 2013; 49: 15-21.
  42. Çekmez F, Aydemir G, Aydinoz S, Pirgon O, Genc FA, Tunc T, Sarıcı SÜ. Low 25-hydroxyvitamin D level and adiponectin is associated with insulin sensitivity in large gestational age infants. Cytokine 2012; 59: 156-158.
  43. Tayman C, Çekmez F, Kafa IM, Canpolat FE, Cetinkaya M, Uysal S, Tunc T, Sarıcı SÜ. Beneficial effects of nigella sativa oil on intestinal damage in necrotizing enterocolitis. J Invest Surg 2012; 25: 286-294.
  44. Sarıcı D, Sarıcı SÜ. Neonatal hypokalemia. Research and Reports in Neonatology 2012; 2: 15-19.
  45. Sarıcı SÜ, Dabak O, Erdinç K, Okutan V, Lenk MK. An unreported complication of intravenously administered ibuprofen: gastrointestinal bleeding. Eur Rev Med Pharmacol Sci 2012; 16: 325-327.
  46. Çetinkaya M, Çekmez F, Canpolat FE, Akın O, Kozan S, Atabek C, Sarıcı SÜ. Oesophageal atresia in a neonate with a familial translocation t(1;13)(p8;q12). Genet Couns 2012; 23: 73-75.
  47. Ortatatlı M, Sarıcı SÜ. Laboratory criteria for severe Crimean-Congo haemorrhagic fever. Turk J Med Sci 2012; 42: 365-366.
  48. Çekmez F, Canpolat FE, Pirgon Ö, Cetinkaya M, Aydınöz S, Süleymanoğlu S, İpçioğlu OM, Sarıcı SÜ. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance. Cytokine 2011; 56: 387-391. Epub 2011 Jul 13.
  49. Çekmez F, Canpolat FE, Çetinkaya M, Aydınöz S, Aydemir G, Karademir F, İpçioğlu OM, Sarıcı SÜ. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. Eur Cytokine Netw 2011; 22: 113-117.
  50. Çekmez F, Canpolat FE, Çetinkaya M, Pirgon Ö, Aydınöz S, Ceylan OM, İpçioglu OM, Sarıcı SÜ. IGF-I and visfatin levels in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2012; 49: 120-124. Epub 2011 Jun 7.
  51. Çekmez F, Canpolat FE, Erdinç K, Çetinkaya M, Akın O, Pamuk U, Sarıcı SÜ. Response to hepatitis B vaccine differs by birthweight among neonates. Vaccine 2011; 29: 3096-3097. Epub 2011 Mar 6.
  52. Canpolat FE, Çekmez F, Sarıcı SÜ, Korkmaz A, Yurdakök M. Insulin-Like growth factor-1 levels in twins and its correlation with discordance. Twin Res Hum Genet 2011; 14: 94-97.
  53. Güran Ş, Rosti RO, Sarıcı SÜ, Torun D, Kozan S, Bahçe M. Rare chromosomal complement of trisomy 21 in a boy conceived only by IVF. Reprod Biomed Online 2010; 21: 721-722. Epub 2010 Aug 16.
  54. Balamtekin N, Gülgün M, Sarıcı SÜ, Ünay B, Dündaröz MR. Metoclopramide induced intermittent opisthotonos in infant. Cent Eur J Med 2010; 5: 224-226.
  55. Altınsoy Hİ, Mutlu FM, Güngör R, Sarıcı SÜ. Combination of laser photocoagulation and intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 2010; 41: e1-5. doi: 10.3928/15428877-20100215-03. [Epub ahead of print].
  56. Bülbül A, Karadağ A, Köklü E, Pamuk U, Sarıcı SÜ. Anaphylactic shock due to hepatitis B immunoglobulin in a newborn. J Matern Fetal Neonatal Med 2010; 23: 1257-1259. Mar 9. [Epub ahead of print].
  57. Saldır M, Sarıcı SÜ, Mutlu FM, Mocan C, Altınsoy Hİ, Özcan O. An analysis of neonatal risk factors associated with the development of ophthalmologic problems at infancy and early childhood: a study of premature infants born at or before 32 weeks of gestation. J Pediatr Ophthalmol Strabismus 2010; 47: 331-337. Epub 2010 Feb 23.
  58. Saldır M, Sarıcı SÜ, Bakar EE, Özcan O. Neurodevelopmental status of preterm newborns at infancy, born at a tertiary care center in Turkey. Am J Perinatol 2010; 27: 121-128. Epub 2009 Jun 5.
  59. Sarıcı SÜ. Incidence and etiology of neonatal hyperbilirubinemia. J Trop Pediatr 2010; 56: 128-129. 2009 Jun 5 [Epub ahead of print].
  60. Tunc T, Oter S, Güven A, Topal T, Kul M, Korkmaz A, Ongürü O, Sarıcı Ü. Protective effect of sulfhydryl-containing antioxidants against ischemia/reperfusion injury of prepubertal rat intestine. J Gastroenterol Hepatol 2009; 24: 681-687. Epub 2009 Dec 1.
  61. Köklü E, Sarıcı SÜ, Altun D, Erdeve Ö. Nicolau syndrome induced by intramuscular vitamin K in a premature newborn. Eur J Pediatr 2009; 168: 1541-1542. Epub 2009 Mar 11.
  62. Köklü E, Karadağ A, Tunç T, Altun D, Sarıcı SÜ. Congenital cytomegalovirus infection associated with severe lung involvement in a preterm neonate: a causal relationship? Eur J Pediatr 2009; 168: 1409-1412. Epub 2009 Feb 18.
  63. Tunç T, Bülbül A, Erdinç K, Sarici SÜ, Gül D, Özcan O. The Wiedemann-Rautenstrauch or neonatal progeroid syndrome: report of a patient with hypospadias. Genet Couns 2009; 20: 367-371.
  64. Okutan V, Kürekçi AE, Sarıcı SÜ, Atay AA, Yozgat Y, Azık F, Lenk MK, Özcan O. Neutrophil hypersegmentation in children receiving angiotensin converting enzyme inhibitors. Turk J Pediatr 2008; 50: 438-442.
  65. Mutlu FM, Altınsoy Hİ, Mumcuoğlu T, Kerimoğlu H, Kılıç S, Kul M, Sarıcı SÜ, Alpay F. Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey: frequency, outcomes, and risk factor analysis. J Pediatr Ophthalmol Strab 2008; 45: 291-298.
  66. Erdeve Ö, Sarıcı SÜ, Sarı E, Gök F. Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol 2008; 23: 1565-1567.
  67. Tunç T, Kul M, Yaman H, Demirkaya E, Saldır M, Kurt İ, Sarıcı SÜ, Alpay F. Chitotriosidase activity in human milk from mothers of premature and full-term infants during the first month of lactation. Clin Biochem 2008; 41: 693-696.
  68. Sarıcı SÜ, Saldır M. Genetic factors in neonatal hyperbilirubinemia and kernicterus. Turk J Pediatr 2007; 49: 245-249.
  69. Mutlu FM, Sarıcı SÜ. Retinopathy of prematurity: incidence and risk factors. Expert Rev Ophthalmol 2007; 2: 267-274.
  70. Sarıcı SÜ. Urinary tract infection and neonatal hyperbilirubinemia. Turk J Pediatr 2007; 49: 113.
  71. Akyüz A, Dede M, Çetintürk A, Yavan T, Yenen MC, Sarıcı SÜ, Dilek S. Self-application of complementary and alternative medicine by patients with gynecologic cancer. Gynecol Obstet Invest 2007; 64: 75-81.
  72. Sarıcı SÜ, Yurdakök M. Neonatal resuscitation with room air or oxygen: a review. Asian Journal of Paediatric Practice 2006; 10: 38-42.
  73. Ünay B, Akın R, Sarıcı SÜ, Gök F, Kurt İ, Gökçay E. Evaluation of renal tubular function in children taking anti-epileptic treatment. Nephrology 2006; 11: 485-488.
  74. Kürekçi AE, Sarıcı SÜ, Karaoğlu A, Ulaş ÜH, Atay AA, Serdar MA, Akın R, Özcan O. Effects of iron deficiency versus iron deficiency anemia on brainstem auditory evoked potentials in infancy. Turk J Pediatr 2006; 48: 334-339.
  75. Kürekçi AE, Atay AA, Demirkaya E, Sarıcı SÜ, Özcan O. Immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia and mumps. J Pediatr Hematol Oncol 2006; 28: 170-172.
  76. Bulun A, Sarıcı SÜ, Uysal Soyer Ö, Tekşam Ö, Yurdakök M, Çağlar M. The triad of nesidioblastosis, congenital neuroblastoma and glomerulocystic disease of the newborn: a case report. Turk J Pediatr 2005; 47: 298-302.
  77. Kürekçi AE, Atay AA, Sarıcı SÜ, Özcan O. Response. Pediatr Hematol Oncol 2005; 22: 439-440.
  78. Atay AA, Kısmet E, Türkbay T, Kocaoğlu M, Demirkaya E, Sarıcı SÜ, Congoloğlu A, Gökçay E. Bone mass toxicity associated with inhalation exposure to toluene. Biol Trace Elem Res 2005; 105: 197-203.
  79. Akın R, Ünay B, Sarıcı SÜ, Ulaş Ü, Gökçay E. Evaluation of visual evoked potentials in children with headache. Turk J Pediatr 2005; 47: 150-152.
  80. Kürekçi AE, Atay AA, Sarıcı SÜ, Yeşilkaya E, Şenses Z, Okutan V, Özcan O. Is there a relationship between childhood helicobacter pylori infection and iron deficiency anemia? J Trop Pediatr 2005; 51: 166-169.
  81. Kürekçi AE, Atay AA, Sarıcı SÜ, Özcan O. Complete platelet recovery after treatment of helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: a case report. Pediatr Hematol Oncol 2004; 21: 593-596.
  82. Sarıcı SÜ, Serdar MA, Erdem G, Alpay F, Tekinalp G, Yurdakök M, Yiğit Ş, Gökçay E. Plasma ionized magnesium levels in neonatal respiratory distress syndrome. Biol Neonate 2004; 86: 110-115.
  83. Sarıcı SÜ, Candemir G, Alpay F. How reliable is clinical assessment in neonatal jaundice? Acta Paediatr 2004; 93: 857-858.
  84. Sarıcı SÜ, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, Yurdakök M, Yiğit Ş. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004; 113; 775-780.
  85. Ünay B, Sarıcı SÜ, Bulakbaşı N, Akın R, Gökçay E. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis associated with hepatitis A infection. Pediatr Int 2004; 46: 171-173.
  86. Türkbay T, Sarıcı SÜ, Kısmet E, Akay C, Dündaröz MR, Balcıoğlu İ. Blood lead levels in glue sniffers. Biol Trace Elem Res 2004; 98: 45-49.
  87. Ünay B, Sarıcı SÜ, Ulaş HÜ, Akın R, Alpay F, Gökçay E. Nutritional effects on auditory brainstem maturation in healthy term infants. Arch Dis Child Fetal Neonatal Ed 2004; 89: F177-179.
  88. Sarıcı SÜ, Serdar MA, Erdem G, Alpay F. Evaluation of plasma ionized magnesium levels in neonatal hyperbilirubinemia. Pediatr Res 2004; 55: 243-247.
  89. Sarıcı SÜ, Kısmet E, Türkbay T, Kocaoğlu M, Aydın Hİ, Dündaröz MR, Balcıoğlu İ. Bone mineral density in children with nocturnal enuresis. Int Urol Nephrol 2003; 35: 381-385.
  90. Sarıcı SÜ. ABO incompatibility: which is hemolytic, which is severe? Ital J Pediatr 2003; 29: 341-342.
  91. Sarıcı SÜ. Familial hyperbilirubinemia in ABO-incompatible neonates. Pediatrics 2003; 112: 1453-1454.
  92. Sarıcı SÜ, Kul M, Alpay F. Neonatal jaundice coinciding with or resulting from urinary tract infection? Pediatrics 2003; 112: 1212-1213.
  93. Njolstad PR, Sagen JV, Bjorkhaug L, Odili S, Shehadeh N, Bakry D, Sarıcı SÜ, Alpay F, Molnes J, Molven A, Sovik O, Matschinsky FM. Permanent neonatal diabetes caused by glucokinase deficiency: Inborn error of the glucose-insulin signaling pathway. Diabetes 2003; 52: 2854-2860.
  94. Sarıcı SÜ, Şahin M, Yurdakök M. Topical N-acetylcysteine treatment in neonatal ichthyosis. Turk J Pediatr 2003; 45: 245-247.
  95. Ünay B, Sarıcı SÜ, Vurucu S, İnanç N, Akın R, Gökçay E. Evaluation of bone mineral density in children with cerebral palsy. Turk J Pediatr 2003; 45: 11-14.
  96. Dündaröz MR, Türkbay T, Akay C, Sarıcı SÜ, Aydın A, Denli M, Gökçay E. Antioxidant enzymes and lipid peroxidation in adolescents with inhalant abuse. Turk J Pediatr 2003; 45: 43-45.
  97. Dündaröz MR, Sarıcı SÜ, Türkbay T, Baykal B, Kocaoğlu M, Aydın Hİ, Gökçay E. Evaluation of bone mineral density in chronic glue sniffers. Turk J Pediatr 2002; 44: 326-329.
  98. Dündaröz MR, Türkbay T, Sarıcı SÜ, Akay C, Sayal A, Denli M. Selenium and zinc levels in volatile substance abusers. Biol Trace Elem Res 2002; 88: 119-123.
  99. Sarıcı SÜ, Alpay F, Yeşilkaya E, Özcan O, Gökçay E. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report. Turk J Pediatr 2002; 44: 248-250.
  100. Sarıcı SÜ. The practice parameter for the management of hyperbilirubinemia. Acta Paediatr 2002; 91: 487.
  101. Sarıcı SÜ, Yurdakök M, Serdar MA, Oran O, Erdem G, Tekinalp G, Yiğit S. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics 2002; 109(4): e53.
  102. Dündaröz R, Sarıcı SÜ, Taşçılar ME, Alpay F, Özcan O, Gökçay E. L’hyperbilirubinemie conjugee compliquant la maladie hemolytique secondaire a l’incompatibilite ABO. Revista Romana de Pediatrie 2002; LI: 171-173.
  103. Sarıcı SÜ, Alpay F, Dündaröz MR, Özcan O, Gökçay E. Fiberoptic phototherapy versus conventional daylight phototherapy for hyperbilirubinemia of term newborns. Turk J Pediatr 2001;43: 280-285.
  104. Tekinalp G, Sarıcı SÜ, Erdinç AS, Göğüş S, Balcı S, Gürgey A. Lethal hydrops fetalis due to congenital dyserythropoietic anemia in a newborn: association of a new skeletal abnormality. Pediatr Hematol Oncol 2001; 18: 537-542.
  105. Dündaröz MR, Denli M, Uzun M, Aydın Hİ, Sarıcı SÜ, Yokuşoğlu M, Ülgen S. Analysis of heart rate variability in children with primary nocturnal enuresis. Int Urol Nephrol 2001; 32: 393-397.
  106. Dündaröz MR, Sarıcı SÜ, Denli M, Aydın Hİ, Kocaoğlu M, Özışık T. Bone age in children with nocturnal enuresis. Int Urol Nephrol 2001; 32: 389-391.
  107. Sarıcı SÜ, Yurdakok M, Ünal Ş. Acute gastric dilatation complicating the use of mydriatics in a preterm newborn. Pediatr Radiol 2001; 31: 581-583.
  108. Ünay B, Sarıcı SÜ, Gül D, Akın R, Gökçay E. Adams-Oliver syndrome: further evidence for autosomal recessive inheritance. Clin Dysmorphol 2001; 10: 223-225.
  109. Sarıcı SÜ, Okutan V, Dündaröz MR, Serdar MA, Akın R, Deda G, Gökçay E. The effect of iron supplementation on visual evoked potentials in infants with iron-deficiency anemia. J Trop Pediatr 2001; 47: 132-135.
  110. Sarıcı SÜ, Alpay F, Dündaröz MR, Gökçay E. Neonatal diabetes mellitus: patient report and review of the literature. J Pediatr Endocrinol Metab 2001; 14: 451-454.
  111. Sarıcı SÜ, Serdar MA, Dündaröz MR, Ünay B, Akın R, Deda G, Gökçay E. Brainstem auditory-evoked potentials in iron-deficiency anemia. Pediatr Neurol 2001; 24: 205-208.
  112. Serdar MA, Sarıcı SÜ, Kurt I, Alpay F, Okutan V, Kurnaz L, Kutluay T. The role of erythrocyte protoporphyrin in the diagnosis of iron deficiency anemia of children. J Trop Pediatr 2000; 46: 323-326.
  113. Okutan V, Lenk MK, Sarıcı SÜ, Dündaröz R, Akın R, Gökçay E. Efficacy and safety of rectal thiopental sedation in outpatient echocardiographic examination of children. Acta Paediatr 2000; 89: 1340-1343.
  114. Aydın Hİ, Sarıcı SÜ, Alpay F, Gökçay E. Thoracic ectopic kidney in a child: a case report. Turk J Pediatr 2000; 42: 253-255.
  115. Alpay F, Sarıcı SÜ, Tosuncuk HD, Serdar MA, İnanç N, Gökçay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 2000; 106(2): E16.
  116. Okutan V, Sarıcı SÜ, Dündaröz MR, Akmeşe Y, Gökçay E. Cerebral salt wasting syndrome in a brain injury caused by acute dehydration. Int Pediatr 2000; 15: 110-113.
  117. Sarıcı SÜ, Alpay F, Okutan V, Gökçay E. Is a standard protocol necessary for oscillometric blood pressure measurement in term newborns? Biol Neonate 2000; 77: 212-216.
  118. Kürekçi AE, Atay AA, Sarıcı SÜ, Zeybek C, Köseoğlu V, Özcan O. Effect of iron therapy on the whole blood platelet aggregation in infants with iron deficiency anemia. Thromb Res 2000; 97: 281-285.
  119. Sarıcı SÜ, Alpay F, Ünay B, Özcan O, Gökçay E. Double versus single phototherapy in term newborns with significant hyperbilirubinemia. J Trop Pediatr 2000; 46: 36-39.
  120. Dündaröz MR, Sarıcı SÜ, Okutan V, Atilla MK, Denli M, Özışık T. HLA antigens in nocturnal enuresis. Int Urol Nephrol 1999; 31: 811-815.
  121. Sarıcı SÜ, Alpay F, Ünay B, Özcan O, Gökçay E. Comparison of the efficacy of conventional special blue light phototherapy and fiberoptic phototherapy in the management of neonatal hyperbilirubinaemia. Acta Paediatr 1999; 88: 1249-1253.
  122. Alpay F, Sarıcı SÜ, Okutan V, Erdem G, Özcan O, Gökçay E. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999; 88: 216-219.
  123. Köseoğlu V, Kürekçi AE, Sarıcı Ü, Atay AA, Ozcan O. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr 1998; 157: 806-810.
  124. Akın R, Okutan V, Sarıcı Ü, Altunbaş A, Gökçay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998; 19: 129-131.
  125. Lenk MK, Alehan D, Çeliker A, Alpay F, Sarıcı Ü. Bruce treadmill test in healthy Turkish children: endurance time, heart rate, blood pressure and electrocardiographic changes. Turk J Pediatr 1998; 40: 167-175.
  126. Dündaröz R, Akın R, Okutan V, Sarıcı Ü, Alpay F, Gökçay E. Acquired cytomegalovirus infection in infants. A case successfully treated with ganciclovir. Presse Med 1997; 26: 1000-1001.